US EditionCalls for probe into cystic fibrosis drugmaker to be reopened - Juta MedicalBrief
Summary by Medical Brief
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Calls for probe into cystic fibrosis drugmaker to be reopened - Juta MedicalBrief
Health lobbyists are demanding that the Competition Commission reopen its investigation into the manufacturers of Trikafta, for the treatment of cystic fibrosis, which is expected to be added to the WHO’s Essential Medicines List but will be unaffordable for half of all patients in South Africa. Last week, the SA Cystic Fibrosis Association (SACFA) and the Health Justice Initiative (HJI), handed over information to the commission, demanding it r…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
